Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book

International Journal of Cancer Management

The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences

Home
Current IssueAll IssuesIn Press ArticlesAccepted ManuscriptsSearch
Instructions
Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormAnnouncementSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)

1. New Substituted 6,7-Dimethoxy-N-phenyl-2-(piperazin-1-yl)quinazolin-4-amine Derivatives: Synthesis, Characterization, Cytotoxicity against SKBR3 and Trastuzumab Resistance SKBR3 Cell Lines, and EGFR/HER2 Dual Kinase Inhibition Assay

- Bakshi V. , et al.

2. Exploring Bevacizumab's Role in Gynecological Cancers: An Up-to-Date Narrative Review Focusing on Ovarian Cancer

- Liolis E. , et al.

3. Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody

- Bai Y. , et al.

4. Anti-drug antibodies in the current management of cancer

- Borregón M. , et al.

5. Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences

- Saffari F. , et al.

6. Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis

- Bar-Or A. , et al.

7. Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside

- Bray-French K. , et al.

8. The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies

- Vaisman-Mentesh A. , et al.